Stagezero Life Sciences Stock Probability of Future Stock Price Finishing Over 0.04

SZLS Stock  CAD 0.04  0.00  0.00%   
StageZero Life's future price is the expected price of StageZero Life instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of StageZero Life Sciences performance during a given time horizon utilizing its historical volatility. Check out StageZero Life Backtesting, StageZero Life Valuation, StageZero Life Correlation, StageZero Life Hype Analysis, StageZero Life Volatility, StageZero Life History as well as StageZero Life Performance.
  
As of the 1st of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.06, while Price To Sales Ratio is likely to drop 1.27. Please specify StageZero Life's target price for which you would like StageZero Life odds to be computed.

StageZero Life Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of StageZero Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for StageZero Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
StageZero Life generated a negative expected return over the last 90 days
StageZero Life has some characteristics of a very speculative penny stock
StageZero Life has high likelihood to experience some financial distress in the next 2 years
StageZero Life Sciences has accumulated 1.8 M in total debt. StageZero Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist StageZero Life until it has trouble settling it off, either with new capital or with free cash flow. So, StageZero Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StageZero Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StageZero to invest in growth at high rates of return. When we think about StageZero Life's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 2.88 M. Net Loss for the year was (12.53 M) with profit before overhead, payroll, taxes, and interest of 1.18 M.
StageZero Life Sciences has accumulated about 754.87 K in cash with (809.15 K) of positive cash flow from operations.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

StageZero Life Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of StageZero Stock often depends not only on the future outlook of the current and potential StageZero Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. StageZero Life's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding99.4 M
Cash And Short Term Investments15.7 K

StageZero Life Technical Analysis

StageZero Life's future price can be derived by breaking down and analyzing its technical indicators over time. StageZero Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of StageZero Life Sciences. In general, you should focus on analyzing StageZero Stock price patterns and their correlations with different microeconomic environments and drivers.

StageZero Life Predictive Forecast Models

StageZero Life's time-series forecasting models is one of many StageZero Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary StageZero Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about StageZero Life Sciences

Checking the ongoing alerts about StageZero Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for StageZero Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
StageZero Life generated a negative expected return over the last 90 days
StageZero Life has some characteristics of a very speculative penny stock
StageZero Life has high likelihood to experience some financial distress in the next 2 years
StageZero Life Sciences has accumulated 1.8 M in total debt. StageZero Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist StageZero Life until it has trouble settling it off, either with new capital or with free cash flow. So, StageZero Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StageZero Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StageZero to invest in growth at high rates of return. When we think about StageZero Life's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 2.88 M. Net Loss for the year was (12.53 M) with profit before overhead, payroll, taxes, and interest of 1.18 M.
StageZero Life Sciences has accumulated about 754.87 K in cash with (809.15 K) of positive cash flow from operations.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Other Information on Investing in StageZero Stock

StageZero Life financial ratios help investors to determine whether StageZero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in StageZero with respect to the benefits of owning StageZero Life security.